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Capsidframeshift mechanism during polyprotein synthesis to balance appropriate ratios
of structural proteins and enzymes. To investigate the requirements for individual precursors in retrovirus
assembly, we modiﬁed the polyprotein repertoire of Mason-Pﬁzer monkey virus (M-PMV) by mutating the
frameshift sites to imitate the polyprotein organization of Rous sarcoma virus (Gag-Pro and Gag-Pro-Pol) or
Human immunodeﬁciency virus (Gag and Gag-Pro-Pol). For the “Rous-like” virus, assembly was impaired
with no incorporation of Gag-Pro-Pol into particles and for the “HIV-like” virus an altered morphogenesis
was observed. A mutant expressing Gag and Gag-Pro polyproteins and lacking Gag-Pro-Pol assembled
intracellular particles at a level similar to the wild-type. Gag-Pro-Pol polyprotein alone neither formed
immature particles nor processed the precursor. All the mutants were non-infectious except the “HIV-like”,
which retained fractional infectivity.
© 2008 Elsevier Inc. All rights reserved.Introduction
The formation of a retrovirus particle is initiated by the expression
of polyprotein precursors Gag, Pro and Pol, comprising all structural
proteins and enzymes. The expression strategy controls the proper
ratio of viral components in the immature particles originating either
at the plasma membrane (type-C) or within the cytoplasm (type D).
During or shortly after budding, retroviral Gag polyprotein precursor
is speciﬁcally processed by the viral protease and the immature viral
particle is rearranged to form mature, fully infectious virus.
The proteolytic processing of Mason-Pﬁzer monkey virus (M-PMV)
Gag (Pr78) yields matrix protein (MA, p10), phosphoprotein (pp24/
pp16–18), p12, capsid protein (CA, p27), nucleocapsid protein (NC,
p14), and p4 (Bradac and Hunter, 1984). In addition to the Gag derived
structural proteins the processing of the Gag-Pro polyprotein (Pr95)
results in the release of an NC-dUTPase fusion protein and protease
(PR). The Gag-Pro-Pol polyprotein (Pr180) yields reverse transcriptase
(RT) and integrase (IN).ry and Microbiology and the
chnology, Technická 3, 166 28
l rights reserved.The differential synthesis of two (Gag, Gag-Pol) or three (Gag, Gag-
Pro, Gag-Pro-Pol) polyprotein precursors per virus is regulated by
ribosomal frameshifting from one reading frame to the (−1) one (Jacks
and Varmus, 1985). The exception is the gammaretrovirus genus that
utilizes suppression of a termination codonduring translation of pro and
pol (Yoshinaka et al.,1985). Frameshifting requires two cis-acting signals
in the retroviral mRNA, a slippery sequence for the shift of the ribosome
and a structural element several nucleotides downstreamof the slippery
sequence, which enhances the efﬁciency of the slip (Jacks et al., 1988). A
fraction of the ribosomes translating gag of the M-PMV from unspliced
genomic transcript undergoes the (−1) frameshift (with frequency
∼10–15%) upstream of the end of the gag gene allowing translation
through the pro stop codon. A second (−1) frameshift (2–3%) yields the
pol region in fusionwith both the gag and pro products i.e. Gag-Pro-Pol
precursor. In contrast to M-PMV, most retroviruses employ only one
frameshift event to synthesize only Gag and Gag-Pol precursors.
In addition to regulating the ratios of polyproteins, frameshifting
provides a presence of common transport signal to all Gag related
polyproteins for their targeting to the site of assembly (Farabaugh,
1996; Farabaugh, 2000). In contrast to betaretroviruses (B- and D-type
retroviruses) that form immature particles within the cytoplasm, the
C-type retroviruses concentrate their Gag and Gag-Pol polyproteins at
the plasma membrane where assembly and budding occur simulta-
neously. M-PMV a prototype of D-type morphogenesis, transports its
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assemble into immature capsids that are transported via the vesicular
transport system to the plasma membrane while acquiring env-gene
product (Choi et al., 1999; Sfakianos et al., 2003; Sfakianos and Hunter,
2003; Vlach et al., 2008).
Retroviral protease activity levels vary inversely to their concen-
tration in the virion, controlled by its gene position in the genome. For
instance, in HIV the protease coding sequence is located at the 5′ end
of the pol gene and it is thus expressed only in the pol reading frame. In
avian retroviruses (ASLV, RSV), it is encoded at the 3′-end of the gag
ORF, and it is thus present both in Gag and Gag-Pol molecules. The
lower speciﬁc activity of the RSV protease compared to the HIVmay be
related to its higher concentration in RSV (Grinde et al., 1992). The
active site of the RSV protease contains a serine in contrast to other
retroviruses that contain threonine. Substitution of the threonine for
the serine in the active site results in a 2-fold increase of catalytic
activity of RSV protease (Ridky et al., 1996). In betaretroviruses (M-
PMVandmousemammary tumor virus) and deltaretroviruses (human
T-cell lymphotropic virus), the protease is encoded in a separate
reading frame between the gag and pol genes and intermediate
protease concentrations are therefore incorporated into virions.
Alterations of a proper ratio of the polyprotein precursors dra-
matically impair the assembly, budding and processing (Hung et al.,
1998;Karacostas et al., 1993;Park and Morrow, 1991;Shehu-Xhilaga
et al., 2001). To further investigate the requirement for speciﬁc
polyprotein precursors in assembly, maturation and virion infectivity,
we mutated the frameshift sites in the M-PMV genome to produce
only Gag and Gag-Pro-Pol or Gag-Pro and Gag-Pro-Pol polyproteins
and to generate mutants mimicking HIV or RSV, respectively. Their
properties were compared to the wild-type M-PMV and its D26N
mutant with an inactive protease.
Results
Synthesis, processing, and release of M-PMV wild-type and mutant
polyproteins
All wild-type M-PMV structural proteins and enzymes are
synthesized as polyprotein precursors Gag (G), Gag-Pro (GP) andFig. 1. Organization of the M-PMV gag, pro, and pol genes (upper left corner) and M-PMV fram
ﬁlled boxes indicate the corresponding polyprotein precursors. (−1) FS indicates the framesGag-Pro-Pol (GPP). To study the role of polyprotein precursors ratios
in assembly, maturation and virion infectivity, a series of vectors
with mutated frameshift sites in the M-PMV genome was prepared
(see Fig. 1). The insertion of a single A at the gag-pro frameshift
site prevented the translation of sole Gag polyprotein. Resulting
formation of Gag-Pro and Gag-Pro-Pol polyproteins (GP-GPP)
mimics the organization of polyprotein precursors in Rous sarcoma
virus (RSV) with protease at the 3′ end of Gag (Fig. 1). The insertion
of T in pro-pol frameshift site yielded only the Gag and Gag-Pro-Pol
in G-GPP mutant (Fig. 1). This imitates the strategy in HIV where
protease is encoded in the 5′ terminus of pol. In addition two
control constructs, GPP, expressing only the Gag-Pro-Pol precursor
as a consequence of mutations in both frameshift sites, and G-GP,
with termination codon at the end of gag-pro region were prepared
(Fig. 1).
In order to evaluate the expression and stability of the polyprotein
precursors, transfected COS-1 cells were metabolically labeled and
both the cell- and virus-associated proteins were immunoprecipitated
after a pulse and 4 h chase with rabbit anti-M-PMV capsid protein
serum (Fig. 2). All the anticipated precursors were found in the cells
transfected with the mutant and the wild-type genomes (Fig. 2A).
Despite the alteration of the frameshift sequences, a minor band
corresponding approximately to the molecular weight of Gag-Pro
(Pr95) was observed in the lysates of the cells transfected with
mutants G-GPP or GPP (Fig. 2A). This suggests that an infrequent (−1)
frameshift continued to occur resulting in a small amount of trans-
lation into the (−2) reading frame where there is a stop codon four
amino acids downstream of the slippery sequence. The resulting
polyprotein would therefore have a molecular mass of approximately
95 kDa.
Likewise, all the expected polyproteins for the wild-type and most
of the mutants were found in the cells after the chase, indicating that
there was no signiﬁcant increase in activation of the viral protease or
decrease in protein stability for most of the mutants (Fig. 2B).
However, the Gag-related polyproteins of the GP-GPP and GPP
mutants were signiﬁcantly reduced in the cells during the chase
period (Fig. 2B). This could be either due to nonspeciﬁc degradation
within the cells or due to a higher level of protease produced by these
mutants compared to the wild-type. To exclude this, a D26N proteaseeshift mutants. The open boxes represent open reading frames in the proviral DNA; the
hift site.
Fig. 2. Synthesis and processing of the wild-type and mutant polyprotein precursors.
COS-1 cells transfected with wild-type or mutant proviruses were metabolically labeled
24 h post-transfection with [35S]methionine-cysteine for 15 min and chased for 4 h.
Intracellular proteins after the pulse (A) and chase (B) periods, as well as virus-
associated proteins after the chase period (C) were immunoprecipitated using
polyclonal anti-p27 (M-PMV CA) serum. The Gag-related polyprotein precursors and
their major cleavage product the capsid protein are indicated: Pr180, Gag-Pro-Pol; Pr95,
Gag-Pro; Pr78, Gag; p27, CA. D26N indicates a protease active site mutation in an
otherwise the wild-type background.
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mutant showed a similar pattern of degradation products suggesting
the role of cellular proteases for the observed degradation of
polyproteins (Fig. 3). As expected, no mature CA protein was observed
in the chased cells expressing this mutant. In contrast, the wild-type
and all the other mutants except GPP displayed some intracellular
capsid protein after the 4 h chase (Fig. 2B).
Released mature viral proteins in the culture medium of cells
expressing the wild-type and all the mutants except GPP contained
correctly processed CA protein (Fig. 2C). However, a small amount of
virus-associated unprocessed Gag polyprotein in G-GPP and low level
of CA-related protein of higher molecular weight in GP-GPP suggested
less efﬁcient maturation for these mutants (Fig. 2C). As expected, no
cleavage occurred in the M-PMV D26N protease mutant. The GPP
mutant producing only the Gag-Pro-Pol precursor was neither
processed nor released into the medium even during an overnight
chase (not shown).
The assembly of individual mutants was monitored by fractiona-
tion of cell-associated viral proteins and virus-associated proteins
followed by immunoprecipitation using anti-CA antibody from
samples chased in various times (Fig. 3). The percentage of Gag-
related precursors in the pellet and in the cellular supernatant is
compared in Fig. 4. Nearly 70% of the intracellular wild-type M-PMV
Gag-related polyproteins were found in the pelleted fraction after
the 15 min pulse (Fig. 4) and this relative amount remained constant
during the ﬁrst hour of the chase. Over 50% of the wild-type
precursor molecules were speciﬁcally cleaved during the two-hourchase period (Figs. 3 and 4). In contrast, the initial assembly phase of
the G-GPP mutant was slower as only 20% of polyproteins were
pelleted suggesting that they were incorporated into the particles
during 15 min pulse. However, the proportion of pelletable
polyproteins reached the wild-type level after 30 min chase. Most
of this material likely represented assembled particles since it was
detected in the culture medium after the two-hour chase period.
The GP-GPP and G-GP mutants displayed an intermediate phenotype
between the wild-type and G-GPP as about half of the radiolabeled
precursors was in the pelletable fraction after the pulse period.
However, majority of the intracellular G-GPP, GP-GPP and G-GP
precursors was converted to a pelletable form within the two-hour
chase. Likewise for GPP, about 50% of the radiolabeled Gag-Pro-Pol
precursors were found in the pelletable fraction after the 15 min
pulse period and the amount of the pelletable material of this
mutant exceeded that of the wild-type and other mutants during
the 2 h chase period, but no released proteins were observed in the
medium (Fig. 3).
Since the pelletable cellular fractions might contain assembled
particles but also aggregates, we performed an equilibrium
centrifugation and EM analysis to assess their relative proportion.
All immunoprecipitated material of the GPP mutant migrated to
the bottom of the sucrose gradient (25−55% (w/w)), suggesting
formation of aggregates or large clusters of particles. The presence
of aggregates was supported by the fact that no particles were
detectable by the electron microscopy (data not shown). The wild-
type and the G-GPP proteins migrated to the fraction of sucrose
density ∼1.21 g/ml, indicative of the formation of assembled
immature particles (Klikova et al., 1995;Sakalian et al., 1996). A
surprisingly small portion of GP-GPP mutant polyproteins banded
at this density whilst most of the polyproteins were detected at
the gradient bottom. A pulse chase experiment with a GP-GPP/
D26N double mutant (Fig. 3) showed that released particles of GP-
GPP contained only the Gag-Pro polyprotein, suggesting that
immature particles consisting of both polyproteins were release-
defective or that Gag-Pro-Pol was not incorporated into Gag-Pro
particles.
We further quantiﬁed and compared relative levels of total
polyproteins present in the COS-1 cells and of those assembled into
immature particles (Fig. 5). Multiple autoradiography analyses
revealed an intracellular expression ratio of ∼87:12:0.7 for Gag:Gag-
Pro:Gag-Pro-Pol for the wild-type. However, the proportions incor-
porated into immature particles were different at ∼89:8:2.6, indicat-
ing an increased preferential incorporation of the Gag-Pro-Pol
precursor. Similar results were obtained for the mutant G-GPP
where the Gag-Pro-Pol precursor expression represented ∼8.6%, but
its incorporation reached about 21.6%. No speciﬁc cleavage products
were found by autoradiography of labeled proteins of the intracellular
wild-type and G-GPP mutant particles.
The half-time of processing of thewild-type polyprotein precursors
was approximately 2 h, which is in accordance with previously
published data (Sfakianos and Hunter, 2003;Stansell et al., 2004).
The polyproteins formed from the GP-GPP and G-GP mutants were
processed similarly (determined from the gels in Fig. 3). The
polyproteins of the G-GPP mutant were cleaved less efﬁciently with
the half-time of approximately 2.5 h, which is in agreement with the
fact that released particles contained about 17% (molar) of unprocessed
Gag after 4 h. This is in contrast to the wild-type and other mutants,
capable of particle release, with fully processed released precursors
(Fig. 2C).
Altered polyprotein ratios affect morphogenesis of mutant particles
To determine the morphogenesis of the frameshift mutants, the
localization of the intracellular particles in COS-1 cellswas analyzed by
thin section transmission electron microscopy (Fig. 6). The wild-type
Fig. 3. Assembly, release, and processing of the wild-type andmutant viral particles. COS-1 cells transfected with the wild-type andmutant genomes weremetabolically labeled 24 h
post-transfection with 35S methionine-cysteine for 15 min and chased for 30 min, 1 h and 2 h. The assembled polyprotein precursors were pelleted from the cell lysates by
centrifugation through a 20% (w/v) cushion. The polyprotein precursors from the pellet (P), supernatant (S) and viral particles (V) were immunoprecipitated using polyclonal anti-p27
(M-PMV CA) serum, analyzed by SDS-PAGE, and quantiﬁed on a phosphorimager using ImageQuant software. An experiment withmock transfected cells was conducted as a negative
control (Mock).
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Fig. 4. The assembly of intracytoplasmic particles. COS-1 cells transfectedwith thewild-
type and mutant genomes were metabolically labeled 24 h post-transfection with [35S]
methionine-cysteine for 15 min and chased for 30 min and 2 h. The assembled
polyprotein precursors were pelleted from cell lysates by centrifugation through a 20%
(w/v) cushion. Viral proteins from the pellet, supernatant and culture medium were
immunoprecipitated and quantiﬁed using ImageQuant software. The sum of intensities
of all Gag-related polyproteins plus that of the capsid protein at each time point was
regarded as 100%. Black- and grey-portions of bars indicate the percentage of
intracellular Gag-related precursors present in the pellet and supernatant form the
cell lysates, respectively. The amounts of released (extracellular) viral proteins represent
the white portions of the bars.
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from the plasma membrane (Figs. 6A, B). Similarly, the G-GP mutant
formed intracytoplasmic particleswith thewild-typemorphology that
budded from the cell surface (Figs. 6C, D).
Mutant G-GPP formed both intracytoplasmic particles (Fig. 6E) and
C-type-like particles assembling at the plasma membrane of COS-1
cells (Figs. 6F–H). The latter type was present at various stages of theFig. 5. Comparison of the wild-type and G-GPP mutant precursor ratios in pulse-labeled cel
transfection with [35S]methionine-cysteine. Cell lysates and immature particles isolated fr
p27 (M-PMV CA) serum and the viral proteins were analyzed by phosphorimager. Three i
under the corresponding data column. Table data give the average with the standard d
respectively.assembly, early stage (Fig. 6F) to late stage (Fig. 6H). Notably, we
detected many incomplete particles at the plasma membrane
consisting of segments extended into the cytoplasm without direct
membrane contact (Fig. 6G, black arrows). This is in contrast to the
assembly of common C-type particles (e.g. RSV) whose assembly
requires the interaction of Gag related polyproteins with the plasma
membrane. It is possible that these incomplete structures originated
in the cytoplasm and were transported to the membrane rather than
assembled at the plasma membrane itself. The GP-GPP mutant,
lacking the Gag polyprotein, formed only a few incomplete intracy-
toplasmic particles composed of crescent-shaped segments with the
same approximate diameter as the wild-type (Fig. 6I). Very few GP-
GPP budding structures were observed (Fig. 6J), somewith the C-type-
like morphology.
To analyze the shape and size of immature G-GPP and GP-GPP
particles, the cell lysates of COS-1 cells expressing the wild-type
and both mutants were clariﬁed and viral particles were puriﬁed
through sucrose gradient and analyzed by electron microscopy.
Isolated immature G-GPP particles were spherical with a surface
appearance similar to those of the wild-type M-PMV (Figs. 7A, B).
In comparison to the wild-type immature particles the G-GPP
capsids differed in a diameter, which was slightly larger (90–
130 nm) than that of the wild-type particles (80–100 nm). The
gradient centrifugation analyses of the GP-GPP mutant revealed
particles forming large aggregated clusters (Fig. 7C).
Inﬂuence of frameshift mutations on virus infectivity
Single round infectivity assay was performed to assess the
impact of the altered proportions of polyproteins on viral
replication. With the exception of G-GPP displaying about 20% of
the wild-type infectivity, all the other mutants were non-infectious
(data not shown). To verify that G-GPP was indeed replication
competent, viral growth was monitored over 24 days post-infection
by western blot. The RT assay was not used since the relative levels
of reverse transcriptase in capsid of the mutants varied according
to the altered frameshift sequences. The wild-type virus reached
the maximum of the particle production on the ninth day post-
infection with the level remaining constant thereafter (Fig. 8). The
G-GPP mutant was indeed replication competent, but with a
reduced efﬁciency. Over the course of the 24 day experiment thels and in isolated immature capsids. COS-1 cells were metabolically labeled 24 h post-
om cell lysates of pulse-labeled cells were immunoprecipitated using polyclonal anti-
ndependent experiments were performed and are shown in the gels below the table
eviation. The Pr78, Pr95 and Pr180 polyproteins contain 5, 13 and 27 methionines,
Fig. 6. Frameshift mutants display altered assembly phenotypes. The wild-type (A, B) and the G-GP mutant (C, D) produce the normal intracytoplasmic immature particles (A, C)
which can then be seen budding from the plasma membrane (B, D). Mutant G-GPP (E–H) also produced intracytoplasmic particles (E), but also an abundance of C-type-like
assembling and budding structures at the plasma membrane (F–H). These structures were seen at various levels of completion with some appearing to continue assembling into the
cytoplasmwith visible plasma membrane support (G, black arrows). Mutant GP-GPP (I, J) produced only incomplete and aberrant intracytoplasmic structures (I); although the radius
of curvature of these incomplete rings was similar to that of the wild-type immature particles. GP-GPP budding structures were also observed (J), some of which appeared C-type-
like. The scale bars represent 100 nm.
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Fig. 7. Isolated intracytoplasmic wild-type and mutant particles. Particles isolated by gradient sedimentation were negatively stained with 4% sodium silicotungstate. The wild-type
(A) and G-GPP (B) particles were complete. GP-GPP (C) particles were largely incomplete segments similar to the structures seen in thin section. The scale bars represent 100 nm.
65Z. Kohoutová et al. / Virology 384 (2009) 59–68virus production slowly increased and did not reach a sustained
maximum (Fig. 8).
Discussion
We demonstrate here the effects of different M-PMV polyprotein
ratios on the frameshift efﬁciency, assembly, release, and virus
infectivity. The frameshift efﬁciencies have been determined for
several retroviruses, including HIV-1, where its frequency represents
about 5% in cells and 10% in vitro (Baril et al., 2003;Dinman et al.,
2002;Dulude et al., 2002). Avian sarcoma leukemia virus (Arad et al.,
1995) and Rous sarcoma virus (Jacks and Varmus, 1985) synthesize
Gag-Pol at the level of 4.8% of Gag. Mouse mammary tumor virus
which, similarly to M-PMV, contains separate pro reading frame
between gag and pol, synthesizes up to 20% of Gag-Pro and about 2%
of Gag-Pro-Pol polyprotein precursors compared to Gag, as deter-
mined in both in vitro and in vivo experiments (Chamorro et al., 1992;
Jacks et al., 1987). About 10% efﬁciency of both frameshifts has beenFig. 8. Determination of mutant infectivity. COS-1 cells were transfected with either the
wild-type or G-GPP mutant. Culture medium was collected, the relative quantity of
released particles was measured by western blot for CA, and normalized volume of
medium was used to infect fresh COS-1 cells. Culture medium was collected at 3-day
intervals post-infection. The relative content of capsid protein in the medium post-
infection was similarly quantiﬁed by western blot analysis. Black squares and grey
triangles indicate the wild-type and G-GPP mutant, respectively.estimated for M-PMV (Sonigo et al., 1986). A more recent in vitro study
suggested 16% efﬁciency for the M-PMV gag-pro frameshift (Sakalian
et al., 1996). Our precise determination of the wild-type M-PMV Gag-
related precursors in the cell lysates revealed 12% and 5.5% efﬁciency
for the ﬁrst and second frameshift, respectively, resulting in the
synthesis of 87.1% of Gag, 12.1% of Gag-Pro and 0.7% of Gag-Pro-Pol
precursors. Surprisingly, a detailed quantiﬁcation of the Gag-related
polyproteins in isolatedM-PMVwild-type immature particles showed
only 7.9% of Gag-Pro but 2.6% of Gag-Pro-Pol polyproteins. Similar
results were obtained for the G-GPP mutant where the immature
particles consisted of more than a twofold higher relative amount of
Gag-Pro-Pol compared to its intracellular level. This enrichment of
particles with Gag-Pro-Pol compared to its availability in the cells was
surprising given its inability to independently form particles.
The GP-GPP and GPP mutants were considerably less stable than
thewild-type as observed during a four-hour chase (compare panels A
and B in Fig. 2). One could speculate that this degradation might be
caused by a higher level of viral protease. However, our experiments
with the GP-GPP mutant containing an inactive protease showed
similarly rapid degradation of its intracellular Gag-related polypro-
teins. Thus a possible explanation for the instability of the longer
polyproteins could be that these mutants do not express the complete
Gag but only C-terminally truncated polyprotein lacking p4 protein
and 15 amino acids from NC. We have shown previously that this
proline-rich protein is not essential for assembly of immature
particles, since M-PMV Gag lacking the p4 protein efﬁciently
assembles in vitro (Nermut et al., 2002; Rumlova-Klikova et al.,
2000). However, the p4 domain in M-PMV Gag transiently interacts
with a cytosolic chaperonin TRiC (Hong et al., 2001), which prevents
aggregation and proteolytic degradation of newly translated proteins
(Clarke, 2006; Kubota et al., 2006). The truncation of p4 triggered a
degradation of the entire Gag and this mutant produced a lower level
of self assembled capsids (Hong et al., 2001). In consonancewith these
interpretations a majority of GP-GPP intracytoplasmic particles was
incomplete and formed aggregates. One can speculate that also the C-
terminal sequence of nucleocapsid, which is not present in GP-GPP
mutant, can contribute to the instability of polyprotein and to
decrease the amount of cell-associated Gag polyproteins. However,
the results from experiments in which the substantial part of the C-
terminal sequence of M-PMV NC was removed and assembly of
immature particles was not impaired (Michaela Rumlová, personal
communication) show that the p4 protein assists very likely in the
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assembly. Despite inefﬁcient assembly, the presence of 27 kDa capsid
protein in released particles indicated a partial maturation of GP-GPP
mutant. Nevertheless, it was non-infectious and partially decelerated
in the release. Released particles of GP-GPP mutant with inactive
protease lacked Gag-Pro-Pol, likely to the impaired capability of large
Gag-Pro-Pol polyprotein to co-assemble with Gag-Pro. One explana-
tion could be that these Gag polyproteins are not correctly folded to an
assembly competent form and proper intermolecular interactions
between Gag-polyproteins do not arise before assembly. Another
possible explanation for the instability of the longer polyproteins in
the absence of the Gag polyprotein is their inefﬁcient assembly due to
steric problems associated with their accommodating into particles of
∼90 nm diameter.
The GPP mutant, producing only the largest Gag-related poly-
protein, did not form any detectable particles. Several studies have
focused on expression of HIV Gag-Pol in the absence of Gag; however
the results depended upon the expression system and the protease
activity. In COS-1 cells (Park and Morrow, 1991; Smith et al., 1993),
293T cells (Chiu et al., 2002), and CV-1 cell (Karacostas et al., 1993) the
expression of Gag-Pol alone resulted in intracellular protease activa-
tion, precursor processing, and failure of particle formation and
budding. A low level of the reverse transcriptase activity was detected
in the medium of the COS cells transfected with the HIV Gag-Pol, but
particle formation was not conﬁrmed (Park and Morrow, 1992). In
contrast, RSV (Oertle et al., 1992) and M-MuLV (Felsenstein and Goff,
1988) Gag-Pol failed to form particles when expressed alone even
though no precursor processing in the cells was observed. These
reports demonstrate that intracytoplasmic Gag-Pol particle formation
generally does not occur. Consistently with previously published data
for other retroviruses (Gheysen et al., 1989; Haffar et al., 1990;
Hoshikawa et al., 1991; Smith et al., 1993), our results conﬁrmed that
M-PMV Gag-Pro-Pol polyprotein is dispensable for the assembly.
Interestingly, the G-GPP mutant formed both intracytoplasmic
and membrane bound particles slightly larger (90–130 nm) than
the wild-type (Fig. 7B). However, the membrane associated
particles differed from those typical for C-type retroviruses as
their segments protruded into the cytoplasm suggesting that the
association with the membrane was dispensable for the assembly
or that they were transported to the membrane as partially
assembled fragments (Fig. 6G, arrows). We favor the ﬁrst hypoth-
esis as incomplete particles were not found in the cytoplasm. The
G-GPP processing was signiﬁcantly delayed in comparison to the G-
GP and GP-GPP mutants, which were correctly cleaved with a half-
time of about 2 h. It is likely that the free C-terminus of the PR
domain in the wild-type Gag-Pro facilitates its activation (Bauer-
ova-Zabranska et al., 2005). In contrast, the restricted mobility of
the protease C-terminus in the Gag-Pro-Pol polyprotein of G-GPP
mutant might explain its delayed effect.
In conclusion, the results described here reveal that the stability of
newly synthesized Gag polyproteins within the host cells signiﬁcantly
inﬂuences the efﬁcient assembly of immature particles. The presence
of complete Gag polyprotein seems to be crucial for the incorporation
of longer Gag-related polyproteins into immature particles. The
maintenance of a proper ratio of polyprotein precursors is important
for infectivity. Interestingly we demonstrate that the ratio of
incorporation of Gag, Gag-Pro, and Gag-Pro-Pol polyproteins into
immature particles is not dictated solely by the proportion of their
synthesis.
Materials and methods
Expression plasmids
To generate frameshift mutations in the M-PMV genome, a vector
pBGUP, containing the gag, pro and pol reading frames (SacI–MscIfragment) in vector pSIT (Andreansky and Hunter, 1994), was used as a
template for site-directed mutagenesis. Oligonucleotides M-PMV-FP:
5′-TACCACCCCATCAGGGAAAACGGGTGGAG-3′, and M-PMV FS: 5′-
AAAGGTTTTGGAAATTTTTTAACTGCGGCCATTGAC-3′ were used to
alter the ﬁrst and second frameshift sites, respectively. These
oligonucleotides were designed to create an insertion of an A and a
T in positions 2317 and 3227 of pSARM4 (Song and Hunter, 2003),
creating a read-through from gag to pro and from pro to pol,
respectively. SacI–Eco72I fragments (2110 bp) of pBGUP, carrying the
appropriate mutations were inserted into pSARM4. A dsDNA linker
(5′-TTAACTAGTTAA-3), containing stop codons in all three reading
frames and a SpeI recognition site, was inserted at the 3′-end of the
pro open reading frame to create the G-GP mutant. All vectors were
veriﬁed by DNA sequencing. The control D26N mutant has been
previously described by Sommerfelt et al. (1992).
Cell lines and transfection
COS-1 (Sigma-Aldrich) cells were grown in Dulbecco's modiﬁed
Eagle's medium (DMEM, Sigma-Aldrich) supplemented with 10% fetal
bovine serum in 5% CO2, at 37 °C. 40–50% conﬂuent cells were
transfected with the appropriate DNA using FuGENE 6 transfection
reagent (Roche Molecular Biochemicals) according to the manufac-
turer's instructions.
Metabolic labeling and immunoprecipitation
COS-1 cells were starved for 10 min in cysteine and methionine
deﬁcient DMEM 24 or 48 h post-transfection and then pulse-labeled
for 15 min with 400 μCi/ml TRAN35S-LABEL labeling mix (ICN
Biomedicals). After washing with DMEM and desired chase period in
complete DMEM, the medium was collected, ﬁltered and adjusted to
1% Triton X-100, 1% sodium deoxycholate and 0.1% concentration of
sodium dodecyl sulfate (SDS). The chased cells, as well as the pulsed
cells, were washed twice with cold Tris-buffered saline (TBS) and
incubated with lysis buffer A (1% Triton X-100, 1% sodium
deoxycholate, 50 mM sodium chloride, and 25 mM Tris–HCl, pH
8.0) at room temperature for 10 min, clariﬁed by centrifugation at
14,000× g for 10 min and the resulting lysate was adjusted to 0.1%
(w/v) SDS. The material was then subjected to centrifugation
through a 20% (w/v) sucrose cushion at 540,000× g for 30 min at
4 °C. Samples were pre-cleared with Staphylococcus A, incubated
overnight at 4 °C with polyclonal antibodies against M-PMV CA and
immunoprecipitated for 30 min at room temperature with Staphy-
lococcus A. Proteins were resolved by 12% SDS-PAGE and visualized
by autoradiography. Protein concentrations were determined using
the Typhoon Variable Mode Imager (Amersham Pharmacia Biotech)
and ImageQuant software (Amersham Pharmacia Biotech). The band
intensity was determined and adjusted to the number of methio-
nines in the particular protein.
Electron microscopy
COS-1 cells scraped from the plate 24 h post-transfection were
ﬁxed for 30 min with 2.5% glutaraldehyde and 1% paraformaldehyde
in 0.1 M sodium cacodylate buffer and post-ﬁxed with 2% osmium
tetroxide OsO4 for 1 h followed by staining with 4% saturated uranyl
acetate. Material dehydrated in increasing acetone concentrations was
sectioned. Negative staining of immature capsids was carried out with
4% sodium silicotungstate at pH 7.2. The samples were analyzed with a
Jeol JEM-1010 at 80 kV.
Isolation of immature capsids
Themethod described previously (Parker and Hunter, 2000; Parker
et al., 2001; Parker and Hunter, 2001) was used. Brieﬂy; the labeled
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lysis buffer (10 mM Tris, 1 mM EDTA, 1% (v/v) Triton X-100). The
cell lysate was clariﬁed by centrifugation at 3000× g and loaded
over a 35% to 75% (w/v) sucrose step gradient in 10 mM Tris buffer,
pH 7.6 and centrifuged for 6 h, at 4 °C, at 25,000 rpm in a Sorvall
TH641 rotor. The 35 to 75% sucrose interface was collected and
dialyzed (cut off 14 kDa) against 10 mM Tris buffer (pH 7.6)
overnight at 4 °C. The particles were pelleted at 22,000× g for
30 min at 4 °C and resuspended in the lysis buffer supplemented
with 500 mM NaCl and further puriﬁed by centrifugation
(25,000 rpm, SorvallTH641 rotor, 30 min, 4 °C) through a 5%–20%
sucrose gradient. 1-ml fractions were analyzed by SDS-PAGE and
the fractions most abundant in virus particles were dialyzed and
centrifuged (22,000× g for 30 min at 4 °C). The puriﬁed particles
were subjected to EM analysis. The material from the sucrose
interface was further separated in a continuous 25–55% (w/w)
sucrose gradient in lysis buffer supplemented with 500 mM NaCl by
ultracentrifugation in a TLS-55 rotor (Beckman) for 2 h at
55,000 rpm and analyzed by SDS-PAGE.
Single-round infectivity assay
The single-round infectivity of M-PMV molecular clones was
determined as described by Song and Hunter (2003). Brieﬂy, COS-1
cells were cotransfected with pMTΔE containing either the wild-type
or the mutant provirus modiﬁed to contain the HIV-1 tat gene in place
of the env gene, and with the glycoprotein expression vector pTMO.
Culture medium was ﬁltered through a 0.45 μm ﬁlter 48 h post-
transfection and analyzed for relative capsid protein content by
western blot. Thirty to 40% conﬂuent GHOST cells (HOS-CD4/LTR-
hGFP) were infected overnight with harvested media, normalized for
CA. GHOST cells were washed with and resuspended in PBS, pH 7.4
supplemented with 5 mM EDTA 48 h post-infection and analyzed for
the expression of GFP by ﬂow cytometry.
Virus infectivity
The infectivity was determined as the level of CA protein released
from infected cells. COS-1 cells were washed twice thoroughly with
complete DMEM 6 h post-transfection and incubated with fresh
medium for 48 h. Themediumwas harvested, ﬁltered and analyzed by
western blot. 30%–40% conﬂuent COS-1 cells were infectedwith virus-
containing culture medium normalized for CA. The cells were washed
12 h post-infection with complete DMEM and cultivated for another
24 days. The culture medium was harvested at 3 day intervals and
virus particles pelleted through a 20% (w/w) sucrose cushion and
analyzed by western blot using a rabbit polyclonal antibody against
M-PMV CA, anti-rabbit HRP-conjugated antibody and Super Signal
West Pico Chemiluminescent Substrate (Pierce). The signals recorded
on a CCD camera were analyzed using AIDA Image Analyzer 2D
Densitometry software (BioTech a.s.).
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